384 related articles for article (PubMed ID: 34502413)
1. The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror.
Martínez MS; Manzano A; Olivar LC; Nava M; Salazar J; D'Marco L; Ortiz R; Chacín M; Guerrero-Wyss M; Cabrera de Bravo M; Cano C; Bermúdez V; Angarita L
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502413
[TBL] [Abstract][Full Text] [Related]
2. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
[TBL] [Abstract][Full Text] [Related]
3. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
4. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
[TBL] [Abstract][Full Text] [Related]
5. Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.
Ahrén B; Foley JE
Diabetologia; 2016 May; 59(5):907-17. PubMed ID: 26894277
[TBL] [Abstract][Full Text] [Related]
6. Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion.
Bethea M; Bozadjieva-Kramer N; Sandoval DA
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34318874
[TBL] [Abstract][Full Text] [Related]
7. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors.
Zhang Y; Wu M; Htun W; Dong EW; Mauvais-Jarvis F; Fonseca VA; Wu H
Sci Rep; 2017 Aug; 7(1):7964. PubMed ID: 28801559
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence.
Liu Y; Hong T
Diabetes Obes Metab; 2014 Feb; 16(2):111-7. PubMed ID: 23668534
[TBL] [Abstract][Full Text] [Related]
11. Progressive change of intra-islet GLP-1 production during diabetes development.
O'Malley TJ; Fava GE; Zhang Y; Fonseca VA; Wu H
Diabetes Metab Res Rev; 2014 Nov; 30(8):661-8. PubMed ID: 24510483
[TBL] [Abstract][Full Text] [Related]
12. The role of dysregulated glucagon secretion in type 2 diabetes.
D'Alessio D
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
Pratley RE; Salsali A
Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
[TBL] [Abstract][Full Text] [Related]
14. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
Whalley NM; Pritchard LE; Smith DM; White A
J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
[TBL] [Abstract][Full Text] [Related]
15. Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells.
Augstein P; Naselli G; Loudovaris T; Hawthorne WJ; Campbell P; Bandala-Sanchez E; Rogers K; Heinke P; Thomas HE; Kay TW; Harrison LC
Diabetes Res Clin Pract; 2015 Dec; 110(3):291-300. PubMed ID: 26515908
[TBL] [Abstract][Full Text] [Related]
16. The entero-insular axis: implications for human metabolism.
Ranganath LR
Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
[TBL] [Abstract][Full Text] [Related]
17. Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.
Miki A; Ricordi C; Sakuma Y; Yamamoto T; Misawa R; Mita A; Molano RD; Vaziri ND; Pileggi A; Ichii H
PLoS One; 2018; 13(5):e0196570. PubMed ID: 29723228
[TBL] [Abstract][Full Text] [Related]
18. Islet α cells and glucagon--critical regulators of energy homeostasis.
Campbell JE; Drucker DJ
Nat Rev Endocrinol; 2015 Jun; 11(6):329-38. PubMed ID: 25850661
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis.
Traub S; Meier DT; Schulze F; Dror E; Nordmann TM; Goetz N; Koch N; Dalmas E; Stawiski M; Makshana V; Thorel F; Herrera PL; Böni-Schnetzler M; Donath MY
Cell Rep; 2017 Mar; 18(13):3192-3203. PubMed ID: 28355570
[TBL] [Abstract][Full Text] [Related]
20. Incretins and Their Endocrine and Metabolic Functions.
Seufert J
Endocr Dev; 2017; 32():38-48. PubMed ID: 28873383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
